Ledger.Open graph →
SEC Form D · filed April 14, 2016

InnAVasc Medical, Inc

Offering
$1.0M
Sold
$520K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Joseph Knight · RESEARCH TRIANGLE PARK, NCExec · DirectorShawn Gage · RESEARCH TRIANGLE PARK, NCExecJeffrey Lawson · RESEARCH TRIANGLE PARK, NCExec · DirectorDani Bolognesi · RESEARCH TRIANGLE PARK, NCDirectorShawn Gage · RESEARCH TRIANGLE PARK, NCExecJoseph Knight · RESEARCH TRIANGLE PARK, NCExec · DirectorRoberto Manson · RESEARCH TRIANGLE PARK, NCExecRoberto Manson · RESEARCH TRIANGLE PARK, NCExecDani Bolognesi · Research Triangle Park, NCDirectorJeffrey Lawson · RESEARCH TRIANGLE PARK, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗